Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy

With increasing incidence and mortality rates, cancer remains one of the most devastating global non-communicable diseases. Restricted dosages and decreased bioavailability, often results in lower therapeutic outcomes, triggering the development of resistance to conventionally used drug/gene therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Moodley, Thashini, Singh, Moganavelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827023/
https://www.ncbi.nlm.nih.gov/pubmed/33430390
http://dx.doi.org/10.3390/pharmaceutics13010071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827023/
https://www.ncbi.nlm.nih.gov/pubmed/33430390
http://dx.doi.org/10.3390/pharmaceutics13010071

Ejemplares similares